These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35452663)

  • 1. Outcomes in Smaller Body Size Adults After HeartMate 3 Left Ventricular Assist Device Implantation.
    Molina EJ; Cowger J; Lee S; Horstmanshof D; Cleveland JC; Goldstein DJ; Mehra MR; Uriel N; Salerno CT; Bourque K; Chuang J; Naka Y
    Ann Thorac Surg; 2022 Dec; 114(6):2262-2269. PubMed ID: 35452663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants.
    Mehra MR; Cleveland JC; Uriel N; Cowger JA; Hall S; Horstmanshof D; Naka Y; Salerno CT; Chuang J; Williams C; Goldstein DJ;
    Eur J Heart Fail; 2021 Aug; 23(8):1392-1400. PubMed ID: 33932272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in patients with smaller body surface area after HeartMate 3 left ventricular assist device implantation.
    Molina EJ; Ahmed S; Jain A; Lam PH; Rao S; Hockstein M; Kadakkal A; Hofmeyer M; Rodrigo ME; Najjar SS; Sheikh FH
    Artif Organs; 2022 Mar; 46(3):460-470. PubMed ID: 34516000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial.
    Sheikh FH; Ravichandran AK; Goldstein DJ; Agarwal R; Ransom J; Bansal A; Kim G; Cleveland JC; Uriel N; Sheridan BC; Chomsky D; Patel SR; Dirckx N; Franke A; Mehra MR
    Circ Heart Fail; 2021 Oct; 14(10):e008360. PubMed ID: 34525837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial.
    Vidula H; Takeda K; Estep JD; Silvestry SC; Milano C; Cleveland JC; Goldstein DJ; Uriel N; Kormos RL; Dirckx N; Mehra MR
    JACC Heart Fail; 2022 Jul; 10(7):470-481. PubMed ID: 35772857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular assist device using a thoracotomy-based implant technique: Multi-Center Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical Techniques Other Than Full Median Sternotomy (HM3 SWIFT).
    Gosev I; Pham DT; Um JY; Anyanwu AC; Itoh A; Kotkar K; Takeda K; Naka Y; Peltz M; Silvestry SC; Couper G; Leacche M; Rao V; Sun B; Tedford RJ; Mokadam N; McNutt R; Crandall D; Mehra MR; Salerno CT
    J Thorac Cardiovasc Surg; 2024 Feb; ():. PubMed ID: 38367698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device Among Women and Men.
    Ramu B; Cogswell R; Ravichandran AK; Cleveland J; Mehra MR; Goldstein D; Uriel N; Dirckx N; Ahmed S; Yuzefpolskaya M
    JACC Heart Fail; 2023 Dec; 11(12):1692-1704. PubMed ID: 37831046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
    Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
    Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
    Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective 1-year outcome follow-up in 200 patients supported with HeartMate 3 and HeartWare left ventricular assist devices in a single centre.
    Mueller M; Hoermandinger C; Richter G; Mulzer J; Tsyganenko D; Krabatsch T; Starck C; Stein J; Schoenrath F; Falk V; Potapov E
    Eur J Cardiothorac Surg; 2020 Jun; 57(6):1160-1165. PubMed ID: 32298426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the HeartMate 3 continuous-flow left ventricular assist device in patients with small body size.
    Tonai K; Fukushima S; Tadokoro N; Kainuma S; Kawamoto N; Kakuta T; Koga-Ikuta A; Watanabe T; Seguchi O; Tsukamoto Y; Fukushima N; Fujita T
    Interact Cardiovasc Thorac Surg; 2022 May; 34(5):902-908. PubMed ID: 35106562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients.
    Cowger JA; Naka Y; Aaronson KD; Horstmanshof D; Gulati S; Rinde-Hoffman D; Pinney S; Adatya S; Farrar DJ; Jorde UP;
    J Heart Lung Transplant; 2018 Jan; 37(1):15-24. PubMed ID: 29153637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial.
    Goldstein DJ; Mehra MR; Naka Y; Salerno C; Uriel N; Dean D; Itoh A; Pagani FD; Skipper ER; Bhat G; Raval N; Bruckner BA; Estep JD; Cogswell R; Milano C; Fendelander L; O'Connell JB; Cleveland J;
    J Heart Lung Transplant; 2018 Jan; 37(1):7-14. PubMed ID: 29154131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of left ventricular size on outcomes after centrifugal-flow left ventricular assist device implantation.
    Molina E; Jain A; Ahmed S; Lam P; Rao S; Hockstein M; Kadakkal A; Hofmeyer M; Rodrigo M; Chou J; Najjar S; Sheikh F
    Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 34788417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
    Florisson DS; Conte SM; De Bono JA; Newcomb AE
    Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
    Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
    J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of adjusted international normalized ratio goal in patients with HeartMate 3 left ventricular assist devices.
    Sowder A; Ather A; Birks E; Kolodziej A; Malyala R; Sieg A; Schadler A; Unger R; Guglin M; Kuan W
    Artif Organs; 2023 Oct; 47(10):1613-1621. PubMed ID: 37184287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Less Invasive Left Ventricular Assist Device Implantation Is Safe and Feasible in Patients With Smaller Body Surface Area.
    Hack M; Wood KL; Bjelic M; Paic F; Vidula H; Cheyne C; Chase K; Tallman M; Bernstein W; Wyrobek JA; Alexis JD; Gosev I
    Innovations (Phila); 2023; 18(5):445-451. PubMed ID: 37794726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.